GRITSTONE BIO, INC.

(GRTS)
  Report
Real-time Estimate Cboe BZX  -  03:52 2022-08-17 pm EDT
4.405 USD   -7.26%
07:01aGritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/15Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors
AQ
08/15Gritstone bio, Inc. Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about GRITSTONE BIO, INC.
07:01aGritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/15Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of GRANI..
AQ
08/15Gritstone bio, Inc. Publishes Interim Results from Gritstone bio’s Phase 1/2 Study..
CI
08/10GRITSTONE BIO : Appoints Dr. Lawrence “Larry” Corey to its Board of Directors ..
PU
08/10GRITSTONE BIO, INC. : Change in Directors or Principal Officers, Financial Statements and ..
AQ
08/10Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors
AQ
08/10Gritstone Appoints Dr. Lawrence “Larry” Corey to Its Board of Directors, Effe..
CI
08/04GRITSTONE BIO : Reports Second Quarter 2022 Financial Results and Provides Business Update..
PU
08/04GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
08/04Earnings Flash (GRTS) GRITSTONE BIO Reports Q2 Revenue $5.5M
MT
08/04TRANSCRIPT : Gritstone bio, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update
AQ
08/04Gritstone bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ende..
CI
07/26Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
07/22GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
07/21Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update ..
AQ
07/21Gritstone Establishes Credit Facility for Up to $80 Million with Hercules Capital and S..
AQ
07/21Gritstone Bio, Inc. Enters into an $80 Million Credit Facility with Hercules Capital, I..
CI
07/19Gritstone bio, Inc. announced that it expects to receive $80 million in funding from He..
CI
07/05Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000 Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2500 Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2000 Dynamic Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell Small Cap Comp Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2000 Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2000 Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000E Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000 Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell Small Cap Completeness Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2500 Value Index
CI
06/24GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000E Value Index
CI
06/23GRITSTONE BIO : 2021 Annual Report
PU
06/21GRITSTONE BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/10GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
06/10Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA)..
AQ
06/10Gritstone Announces Results from Preclinical Study of Its Self-Amplifying Mrna Vaccine ..
CI
06/08Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
06/02Gritstone Earns 2022 Great Place to Work Certification™
AQ
05/31Gritstone Announces Updated Overall Survival Results in Advanced Colorectal Cancer Pati..
AQ
05/31Gritstone Bio, Inc. Announces Updated Overall Survival Results in Advanced Colorectal C..
CI
05/17Gritstone to Participate in H.C. Wainwright Global Investment Conference
AQ
05/11TRANSCRIPT : Gritstone bio, Inc. - Shareholder/Analyst Call
CI
05/09HC Wainwright Lowers Gritstone bio's Price Target to $12 From $15, Maintains Buy Rating
MT
05/06CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Busin..
GL
05/06CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Busin..
GL
05/05GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
05/05Earnings Flash (GRTS) GRITSTONE BIO Posts Q1 Revenue $7.2M, vs. Street Est of $4.21M
MT
05/05Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update
AQ
05/05Gritstone bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/02Gritstone to Release First Quarter 2022 Financial Results on May 5 and Announces Q&A Op..
GL
05/02Gritstone to Release First Quarter 2022 Financial Results on May 5 and Announces Q&A Op..
AQ
04/27Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
04/12Gritstone Presentations at AACR Further Support Expertise in Neoantigen Vaccine Design ..
AQ
03/30Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
03/20GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from S&P Biotechnology Select Industry Index
CI
03/14HC Wainwright Adjusts Gritstone Bio's Price Target to $15 From $24, Maintains Buy Ratin..
MT
03/11Gritstone bio Full-Year 2021 Net Loss Narrows as Revenue Surges
MT
03/11Gritstone bio Files for Up to $250 Million Mixed-Securities Shelf
MT
03/10GRITSTONE BIO, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
03/10Gritstone bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/10Gritstone Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides..
AQ
03/08Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology P..
AQ
02/24Gritstone to Participate in Cowen 42nd Annual Health Care Conference
GL
02/08Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
02/08Gritstone to Participate in Precision Oncology Panel at BIO CEO & Investor Conference
AQ
01/25Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
01/13TRANSCRIPT : Gritstone bio, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, J..
CI
01/13Gritstone Starts Enrollment in Phase 2/3 Trial of Colorectal Cancer Vaccine
MT
01/13Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
AQ
01/13Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
CI
01/10GRITSTONE BIO, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/06UNIVERSITY OF MANCHESTER : Early data for multivariant COVID-19 vaccine booster shows prom..
AQ
01/05GRITSTONE BIO : Announces Positive Clinical Results from First Cohort of a Phase 1 Study (..
PU
01/04GRITSTONE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/04TRANSCRIPT : Gritstone bio, Inc. - Special Call
CI
1  2  3  4  5Next
Upcoming event on GRITSTONE BIO, INC.